Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system

BACKGROUND: Despite the likely association between coronavirus 2019 (COVID-19) mRNA vaccines and cases of myocarditis/pericarditis, the benefit–risk assessment by the Centers for Disease Control (CDC) still showed a favorable balance for the primary series of COVID-19 mRNA vaccinations. Since August...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Congqin, Fu, Fang, Ding, Lingqing, Fang, Jie, Xiao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510366/
https://www.ncbi.nlm.nih.gov/pubmed/36172346
http://dx.doi.org/10.3389/fimmu.2022.938322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510366/
https://www.ncbi.nlm.nih.gov/pubmed/36172346
http://dx.doi.org/10.3389/fimmu.2022.938322

Ejemplares similares